I'm of the same mind @nottawombat, I am averaging up and buying...

I'm of the same mind @nottawombat, I am averaging up and buying as EBR increases as FDA approval get closer and EBR is noticed more, this shareprice will only increase, bring on the last half a year before approvals...and then, this has potential to be the biggest riser on the ASX.

So my philosophy is the opposite to 'never try to catch the falling knife' as it will usually keep falling, with EBR this means that buying as it increases, as it is just going to keep on increasing for the remainder of this year. And then Q1 next year FDA approval will see EBR shoot into the ASX 100 and then ALL eyes will be on this device...its not only best-in-class, its First-&-Best-In-Class. I am quite excited about where EBR will be this time next year but it will be multiples of where the shareprice is now.